Beltsville, MD, United States of America

Cytonix Corporation


USPTO Granted Patents = 26

% Expired Patents = 57.7

Trademarks = 1

Forward Citations = 2,182

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal James F Brown (26 out of 45 patents)

silverMedal Richard A Schneider (3 out of 3 patents)

bronzeMedal Jonathan E Silver (2 out of 14 patents)

4.  Olga V Kalinina (2 out of 7 patents)


Core Competencies:
Hydrophobic Coatings
Low Surface Energy
Touch Screens
Fluorocarbon Treatments
Biological Samples
Porous Surface Compositions
Microbiological Assembly
Miniaturized Assemblies
Coating Processes
Hydrophobic Formulations
Laboratory Apparatus

26 patents:

Company Overview
Cytonix Corporation, based in Beltsville, Maryland, specializes in advanced materials and technologies for various applications, particularly in the fields of biotechnology and medical devices. The company focuses on developing innovative solutions that enhance the performance and reliability of products in these sectors. With a commitment to research and development, Cytonix aims to address complex challenges in healthcare and related industries, contributing to advancements in patient care and technology integration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cytonix Corporation USPTO Patent Assignee Logo
26 Patents

#2 in Beltsville, MD

#163 in Maryland

#12,859 in US

#24,806 in the World

Beltsville, MD (US)
Beltsville, MD, United States of America
Forward Citations = 2,182

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytonix Corporation. Retrieved from https://idiyas.com/company/cytonix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…